TABLE II.
Biochemical sensors for monitoring symptoms related to COVID-19.
Analyte | Type of biosensor | Type of transduction | Matrix analyzed | Limit of detection (LOD) | Reference |
---|---|---|---|---|---|
IFN-γ | Graphene field-effect transistor (gFET)-based aptameric sensor | FET | Sweat | 7.4 × 10−13 mol l−1 | 90 |
IFN-γ, TNF-α, and IL-6 | Graphene field-effect transistor (gFET)-based aptameric sensor | FET | Serum | 4.76 × 10−13 mol l−1 | 91 |
Saliva | 6.08 × 10−13 mol l−1 | ||||
Urine | 6.11 × 10−13 mol l−1 | ||||
Sweat | |||||
Cortisol | Molecularly imprinted polymer-based organic electrochemical transistors (OECTs) | OECTs | Sweat | Not available | 95 |
Antibody-electrochemical sensor | Amperometric | Sweat | 2.21 × 10−10 mol l−1 | 96 | |
Saliva | |||||
Aptamer-field-effect transistor | FET | Sweat | 1 × 10−12 mol l−1 | 97 | |
Na+, K+ | Electrochemical-potentiometric | Sodium and potassium ISE | Interstitial fluids | Not available | 98 |
Na+ | Graphene field-effect transistor | Ion-sensitive field-effect transistor (ISFET) | Interstitial fluids | 2.78 × 10−6 mol l−1 | 94 |